Coltro, Giacomo http://orcid.org/0000-0002-0816-5462
Mannelli, Francesco http://orcid.org/0000-0003-4810-6501
Loscocco, Giuseppe Gaetano http://orcid.org/0000-0002-6241-1206
Mannarelli, Carmela
Rotunno, Giada
Maccari, Chiara
Pancani, Fabiana
Atanasio, Alessandro
Vannucchi, Alessandro Maria http://orcid.org/0000-0001-5755-0730
Guglielmelli, Paola
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (21267, 21267)
Ministero della Salute (NET-2018-12365935)
Article History
Received: 30 March 2022
Revised: 28 April 2022
Accepted: 26 July 2022
First Online: 12 August 2022
Competing interests
: AMV has received speaker fees from Novartis, AOP Health, Incyte, AbbVie, GlaxoSmithKline (GSK), and Bristol Myers Squibb (BMS); and has participated to the advisory boards of Novartis, Incyte, AOP Orphan Pharmaceuticals, AbbVie, GSK, BMS, and Roche. PG has received speaker fees from AbbVie and Novartis, and support for attending meetings from Sanofi. The other authors have nothing to declare.